{"id":"f-18-pbr06","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL3545253","moleculeType":"Small molecule","molecularWeight":"262.28"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"F-18 PBR06 is a radiolabeled version of the compound PBR06, which is designed to bind to specific molecular targets. This allows for the visualization of these targets in the body using positron emission tomography (PET) imaging.","oneSentence":"F-18 PBR06 is a positron-emitting radiopharmaceutical used for imaging purposes.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:12:10.858Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Imaging of neuroinflammation"}]},"trialDetails":[],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["[18-F]PBR06","[F-18] PBR06","[18F]PBR06"],"phase":"phase_3","status":"active","brandName":"[F-18]PBR06","genericName":"[F-18]PBR06","companyName":"Brigham and Women's Hospital","companyId":"brigham-and-women-s-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"F-18 PBR06 is a positron-emitting radiopharmaceutical used for imaging purposes. Used for Imaging of neuroinflammation.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":5,"withResults":1},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":false,"score":2}}